CN111012693B - Multi-effect scalp care composition, preparation method and application thereof - Google Patents
Multi-effect scalp care composition, preparation method and application thereof Download PDFInfo
- Publication number
- CN111012693B CN111012693B CN201911336548.2A CN201911336548A CN111012693B CN 111012693 B CN111012693 B CN 111012693B CN 201911336548 A CN201911336548 A CN 201911336548A CN 111012693 B CN111012693 B CN 111012693B
- Authority
- CN
- China
- Prior art keywords
- scalp care
- scalp
- propylene glycol
- panthenol
- piroctone olamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004761 scalp Anatomy 0.000 title claims abstract description 68
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title abstract description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 15
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 15
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 15
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 13
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims abstract description 13
- 229960003237 betaine Drugs 0.000 claims abstract description 13
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims abstract description 13
- 229940101267 panthenol Drugs 0.000 claims abstract description 13
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 13
- 239000011619 pantothenol Substances 0.000 claims abstract description 13
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims abstract description 13
- OWVLYQRCCIEOPF-QHTZZOMLSA-L zinc;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Zn+2].[O-]C(=O)[C@@H]1CCC(=O)N1.[O-]C(=O)[C@@H]1CCC(=O)N1 OWVLYQRCCIEOPF-QHTZZOMLSA-L 0.000 claims abstract description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 54
- 238000003756 stirring Methods 0.000 claims description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 11
- 229940041616 menthol Drugs 0.000 claims description 11
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000686 essence Substances 0.000 abstract description 20
- 208000003251 Pruritus Diseases 0.000 abstract description 7
- 230000001976 improved effect Effects 0.000 abstract description 7
- 208000001840 Dandruff Diseases 0.000 abstract description 6
- 230000007803 itching Effects 0.000 abstract description 5
- 229940081510 piroctone olamine Drugs 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000003755 preservative agent Substances 0.000 abstract description 3
- 230000002335 preservative effect Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 12
- 210000004209 hair Anatomy 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000001732 sebaceous gland Anatomy 0.000 description 6
- 210000003128 head Anatomy 0.000 description 4
- -1 piroctone olamine salt Chemical class 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241001093152 Mangifera Species 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940083447 azadirachta indica leaf extract Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 229940077445 dimethyl ether Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/008—Preparations for oily hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the field of daily chemicals, and relates to a scalp care composition, a preparation method and application thereof. The invention provides a scalp care composition, which comprises the following components: betaine, dipotassium glycyrrhizinate, panthenol, piroctone olamine, hydrolyzed sodium hyaluronate, and zinc PCA. The composition of the invention contains no water, essence and preservative, and has the functions of controlling oil, keeping moisture, relieving itching and removing dandruff. Compared with the commercially available scalp care essence, the composition disclosed by the invention has a remarkably improved effect on aspects such as dandruff removal, itching relieving and the like.
Description
Technical Field
The invention belongs to the field of daily chemicals, and relates to a multi-effect scalp care composition, a preparation method and application thereof.
Background
Hair nourishing and protecting are increasingly appreciated, and some problems of hair or scalp, such as excessive oil secretion, dandruff or dry and split hair, which often occur in hair nourishing and protecting are always puzzled. The scalp care product is applied to the skin of the head. The healthy scalp does not have the phenomena of itch, greasiness, dryness and the like, and the sebum secretion of the scalp is moderate, so that the hair follicle mouth can not be blocked. The head skin is thin and sensitive, the density of sebaceous glands is relatively high, the sebum secretion is vigorous, and the head skin is different from the facial skin or the body skin in nature. There are many skin care products on the market, but products for scalp care are rare, and studies on scalp health are rare. In addition, the scalp care awareness of people is thin, the main concern is on the health and care of hair, and the importance of scalp health is ignored.
The scalp is also a part of the skin, which has a similar structure to the facial skin, but is more fragile and slimmer than the facial skin, and the thickness of the scalp is about 1.476 mm, and the thickness of the skin on the cheeks is about 1.533 mm; there are many more sebaceous glands on the scalp, with a density of about 144-192 sebaceous glands per square centimeter, about 52-79 sebaceous glands per square centimeter on the forehead, and about 42-78 sebaceous glands per square centimeter on the cheeks, as measured by statistics. That is, the scalp has twice as many sebaceous glands as compared to the forehead, which is most prone to oil, and the scalp is more heavily cared for.
At present, commercially available scalp care products are mainly combined with hair care products such as shampoo, hair conditioner and the like, belong to washing-off products, have limited residence time in the scalp, and have low addition amount of functional components, so that the scalp care products cannot achieve real effects, and are easy to cause scalp sensitivity. Some products have poor transdermal permeability although they are resident products, or have high irritation to the scalp by adding a high concentration of a penetration enhancer such as ethanol.
Disclosure of Invention
The invention aims to provide a scalp care composition which contains no water, essence and preservative and has the functions of controlling oil, moisturizing, relieving itching and removing dandruff.
The invention also aims to provide a scalp care essence containing the scalp care composition.
The above object of the present invention is achieved by the following technical means:
in one aspect, the present invention provides a scalp care composition comprising the ingredients of: betaine, panthenol, dipotassium glycyrrhizinate, piroctone olamine, hydrolyzed sodium hyaluronate and zinc PCA.
In some embodiments, the scalp care composition comprises the following components in weight percent: 0.1-5% of betaine, 0.05-1% of panthenol, 0.01-0.5% of dipotassium glycyrrhizinate, 0.01-0.5% of piroctone olamine salt, 0.001-0.05% of hydrolyzed sodium hyaluronate and 0.01-1% of PCA zinc.
In some embodiments, the scalp care composition comprises the following components in weight percent: betaine 0.1-3%, panthenol 0.1-0.5%, dipotassium glycyrrhizinate 0.05-0.2%, piroctone olamine salt 0.05-0.3%, hydrolyzed sodium hyaluronate 0.01-0.05% and 0.1-0.5%.
In some embodiments, the scalp care composition further comprises menthol.
In some preferred embodiments, the menthol is present in an amount of 0.01 to 0.5% by weight.
In some preferred embodiments, the menthol is present in an amount of 0.05 to 0.3% by weight.
In some embodiments, the scalp care composition further comprises propylene glycol.
In some embodiments, the scalp care composition comprises the following components in weight percent:
a.0.1-5% betaine
B.0.01-0.5% menthol
C.0.01-0.5% dipotassium glycyrrhizinate
D.0.05-1% panthenol
E.0.01-0.5% piroctone olamine salt
F.0.001-0.05% hydrolyzed sodium hyaluronate
G.0.01-1% of zinc PCA
H. The balance being propylene glycol.
In a preferred embodiment, the scalp care composition comprises the following components in weight percent:
a.0.1-3% betaine
B.0.05-0.3% menthol
C.0.05-0.2% dipotassium glycyrrhizinate
D.0.1-0.05% panthenol
E.0.05-0.3% piroctone olamine salt
F.0.01-0.05% hydrolyzed sodium hyaluronate
G.0.1-0.5%
H. The balance being propylene glycol.
The invention also provides application of the scalp care composition in preparing a scalp care product.
In some possible embodiments, the scalp care product is one or more of a hair conditioner, a hair film, a scalp care essence lotion.
In a preferred embodiment, the scalp care product is a scalp care serum.
The invention also provides a preparation method for preparing the scalp care composition, which is characterized by comprising the following steps: 1) Pre-dissolving zinc PCA and piroctone olamine salt in propylene glycol respectively;
2) Putting propylene glycol into a reaction kettle at room temperature;
3) Adding hydrolyzed sodium hyaluronate, stirring and dissolving;
4) Adding betaine, menthol, dipotassium glycyrrhizinate and panthenol, and stirring until the mixture is dissolved uniformly;
5) Adding PCA zinc pre-dissolved by propylene glycol in the step 1), and uniformly stirring;
6) Adding the piroctone olamine salt pre-dissolved by the propylene glycol in the step 1), uniformly stirring, and discharging.
Drawings
FIGS. 1-3 show the results of the moisture retention tests;
FIG. 4 is the results of oil control performance testing;
fig. 5 is a comprehensive result of scalp care effect test.
Detailed Description
The technical solutions of the present invention are further illustrated by the following specific examples, which do not represent limitations to the scope of the present invention. Insubstantial modifications and adaptations of the present invention by others of the concepts fall within the scope of the invention.
The materials and experimental procedures used in the present invention are, unless otherwise specified, conventional materials and procedures.
Example 1 to example 7
TABLE 1
Scalp care essences of examples 1-7 were prepared according to table 1 by the following method:
1) Pre-dissolving zinc PCA and piroctone olamine salt in propylene glycol respectively;
2) Putting the residual propylene glycol obtained in the step 1) into a reaction kettle at room temperature;
3) Adding hydrolyzed sodium hyaluronate, stirring and dissolving;
4) Adding betaine, menthol, dipotassium glycyrrhizinate and panthenol, and stirring until the mixture is dissolved uniformly;
5) Adding PCA zinc pre-dissolved by propylene glycol in the step 1), and uniformly stirring;
6) Adding the piroctone olamine salt pre-dissolved by the propylene glycol in the step 1), uniformly stirring, and discharging.
Comparative examples 1 to 11
TABLE 2
TABLE 3
Scalp care essences of comparative examples 1 to 11, which were prepared in the same manner as in the previous examples, were prepared according to tables 2 and 3.
And (4) performance testing:
12 test volunteers aged 18-45 years, half of each male and female, were recruited randomly. After each volunteer had washed his/her head with a blank shampoo, 0.1ml of the test sample was applied to a defined area of the scalp.
Moisture retention Performance test
Skin moisture content test Probe (instrument software CK-MPA-Multi-Probe-AdapterFB): corneometer CM825 tests scalp stratum corneum moisture.
The test results are shown in FIGS. 1-3.
It can be seen from fig. 1 that the moisturizing effect starts to be greatly improved when the betaine consumption is more than 0.1% (example 2), and the moisturizing effect is limited when the betaine consumption is more than 2% (example 1).
As can be seen from fig. 2, the moisturizing effect starts to be greatly improved when the amount of panthenol used is greater than 0.05% (example 4), and the moisturizing effect is improved only to a limited extent when the amount of panthenol used is greater than 2% (example 1).
From fig. 3, it can be seen that the moisturizing effect starts to be greatly improved when the usage amount of the hydrolyzed sodium hyaluronate is more than 0.001% (comparative example 8), and the moisturizing effect is better and still better improved when the usage amount of the hydrolyzed sodium hyaluronate is more than 0.02% (example 1), but experiments show that the hydrolyzed sodium hyaluronate cannot be completely dissolved in propylene glycol and starts to become turbid when the usage amount of the hydrolyzed sodium hyaluronate is more than 0.05%.
It is demonstrated that the scalp care essence of the present invention has excellent scalp moisturizing effect.
Oil control Performance test
Using a DZCP-04-01 skin elasticity tester (skin elasticity test probe + skin oil test probe): the scalp oil content was tested by a Cutomer dual & Sebumeter (MPA 580& SM 815).
The results of the oil control performance test are shown in fig. 4.
As can be seen from fig. 4, comparative example 3 and comparative example 10, which contained no or only a very small amount of zinc PCA, did not have an inhibitory effect on scalp oil with time; the scalp care essence liquid of the embodiment 1 or 7 can still effectively inhibit scalp grease after being used for 8 hours, and achieves a good oil control effect.
Scalp care efficacy test
The scalp care essence of example 1 and comparative examples 1 and 11 and the commercially available scalp care essence are dispensed into test packaging bottles of 60 parts to 30mL and distributed to test groups (60 persons) for comparison. Once daily for two weeks, the panelists scored the questionnaire test items according to the usage experience. The scoring criteria used were 7 points, 1 being the worst, 7 being the best, the higher the score the better. The final score is displayed as the statistical average score.
The commercially available scalp care essence lotion is a senior nursing essence lotion with aromatic scalp care, and comprises the following components: water, ethanol, dipropylene glycol, menthol, erythritol, PEG/PPG-14/7 dimethyl ether, dipotassium glycyrrhizinate, allantoin, tocopheryl acetate, scutellaria extract, arginine, paeonia root extract, hops extract, zanthoxylum piperitum pericarp extract, iris communis root extract, thiotaurine, ononis Mangifera root extract, polyquaternium-11, perilla leaf extract, polypropylene glycol-13-decyltetradecanol-24, glycerin, PEG-10 methyl ether polydimethylsiloxane, sodium citrate, butylene glycol, citric acid, disodium EDTA, tocopherol, azadirachta indica leaf extract, phenoxyethanol, benzoic acid, and perfume.
The scalp care effect is shown in table 4.
TABLE 4
It can be seen from table 4 that piroctone olamine can significantly improve the anti-dandruff and anti-itching effects (comparative example 1VS example 1); the addition of dipotassium glycyrrhizinate can effectively condition scalp to inhibit scalp itching, and can also assist in enhancing oil control and moisture retention effects (comparative example 11VS example 1).
Compared with the commercially available scalp care essence, the scalp care essence disclosed by the invention contains no water, essence and preservative, and still has the functions of controlling oil, moisturizing, relieving itching and removing dandruff. Surprisingly, the scalp care essence of the present invention is even more effective in these aspects than commercially available scalp care essences. The interaction among the components of the scalp care essence disclosed by the invention is proved, so that the effects of the essence in multiple aspects are effectively improved.
Claims (3)
1. The scalp care essence is characterized by comprising the following components in percentage by weight:
a.0.1-5% betaine
B.0.01-0.5% menthol
C.0.01-0.5% dipotassium glycyrrhizinate
D.0.05-1% panthenol
E.0.01-0.5% piroctone olamine salt
F.0.001-0.05% hydrolyzed sodium hyaluronate
G.0.01-1% zinc PCA
H. The balance being propylene glycol.
2. The scalp care essence according to claim 1, comprising the following components in percentage by weight:
a.0.1-3% betaine
B.0.05-0.3% menthol
C.0.05-0.2% dipotassium glycyrrhizinate
D.0.1-0.5% panthenol
E.0.05-0.3% piroctone olamine salt
F.0.01-0.05% hydrolyzed sodium hyaluronate
G.0.1-0.5% zinc PCA
H. The balance being propylene glycol.
3. A method for preparing the scalp care essence according to claim 1 or 2, comprising the steps of: 1) Pre-dissolving zinc PCA and piroctone olamine salt in propylene glycol respectively;
2) Putting the residual propylene glycol obtained in the step 1) into a reaction kettle at room temperature;
3) Adding hydrolyzed sodium hyaluronate, stirring and dissolving;
4) Adding betaine, menthol, dipotassium glycyrrhizinate and panthenol, and stirring until the mixture is dissolved uniformly;
5) Adding PCA zinc pre-dissolved by propylene glycol in the step 1), and uniformly stirring;
6) Adding the piroctone olamine salt pre-dissolved by the propylene glycol in the step 1), uniformly stirring, and discharging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911336548.2A CN111012693B (en) | 2019-12-23 | 2019-12-23 | Multi-effect scalp care composition, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911336548.2A CN111012693B (en) | 2019-12-23 | 2019-12-23 | Multi-effect scalp care composition, preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111012693A CN111012693A (en) | 2020-04-17 |
CN111012693B true CN111012693B (en) | 2022-12-23 |
Family
ID=70211580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911336548.2A Active CN111012693B (en) | 2019-12-23 | 2019-12-23 | Multi-effect scalp care composition, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111012693B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111821232A (en) * | 2020-06-24 | 2020-10-27 | 名臣健康用品股份有限公司 | Oil-controlling and itching-relieving composition for hair and application thereof |
CN112656709A (en) * | 2021-01-06 | 2021-04-16 | 华熙生物科技股份有限公司 | Skin care compositions and uses thereof |
CN114259446A (en) * | 2022-01-26 | 2022-04-01 | 拉芳家化股份有限公司 | Scalp essence containing nourishing complexing agent |
CN116035986A (en) * | 2022-06-29 | 2023-05-02 | 广州凡岛网络科技有限公司 | Scalp repair composition applied to cosmetic formula |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107875064A (en) * | 2017-12-04 | 2018-04-06 | 珠海伊斯佳科技股份有限公司 | A kind of scalp care compositions |
CN109431883A (en) * | 2018-12-17 | 2019-03-08 | 广州环亚化妆品科技有限公司 | A kind of desquamation compositions and its application |
CN110025658A (en) * | 2019-03-28 | 2019-07-19 | 广州市茗妍化妆品有限公司 | A kind of hair-loss preventing and hair-restoring liquid and preparation method thereof |
-
2019
- 2019-12-23 CN CN201911336548.2A patent/CN111012693B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107875064A (en) * | 2017-12-04 | 2018-04-06 | 珠海伊斯佳科技股份有限公司 | A kind of scalp care compositions |
CN109431883A (en) * | 2018-12-17 | 2019-03-08 | 广州环亚化妆品科技有限公司 | A kind of desquamation compositions and its application |
CN110025658A (en) * | 2019-03-28 | 2019-07-19 | 广州市茗妍化妆品有限公司 | A kind of hair-loss preventing and hair-restoring liquid and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
"Aromatica Argan Repairing Hair Mask";佚名;《http://www.cosdna.com/chs/cosmetic_d2d8357014.html》;20180418;第1-2页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111012693A (en) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111012693B (en) | Multi-effect scalp care composition, preparation method and application thereof | |
CN110934783B (en) | Dandruff-removing and itching-relieving composition containing Chinese herbal medicines, silicone oil-free amino acid shampoo containing composition, and preparation method and application of silicone oil-free amino acid shampoo | |
KR101509608B1 (en) | Composition for improving scalp and hair condition | |
JP6968534B2 (en) | Topical composition containing Pichia anomala and chicory root extract | |
EP2119428B1 (en) | Use and method for reducing hair frizz | |
JP5550863B2 (en) | Cosmetics | |
CN112370393B (en) | Hair washing mousse composition and preparation method and application thereof | |
JP2017193506A (en) | Skin cosmetics | |
CN103816083A (en) | Acne-removing mark-removing transparent emulsion containing basic fibroblast growth factor and preparation method thereof | |
KR101734802B1 (en) | Topical composition including a combination of extracts for reducing signs of skin aging | |
JP6175280B2 (en) | Composition for improving pores | |
JP6052181B2 (en) | Cosmetics | |
RU2671511C1 (en) | Cosmetic composition for hair and head skin care (options) | |
JP2001139436A (en) | Hair tonic and grower | |
KR101656427B1 (en) | Hair composition for reducing irritation of scalp and improving freshness | |
CN113648261A (en) | Ginger shampoo with scalp care effect and preparation method thereof | |
JPH08157337A (en) | Hair cosmetic | |
KR102101951B1 (en) | Cosmetic composition for scalp improvement with the extract of cowslip | |
KR102396487B1 (en) | A hair care composition comprising dead sea salt and silk amino acids | |
JP2019019101A (en) | Skin Cosmetic | |
CN118477021B (en) | Hair loss preventing and itching relieving shampoo containing plant extracts and preparation method thereof | |
TWI815063B (en) | Use of camellia japonica callus extract in skin care | |
JP2019019100A (en) | Skin cosmetics | |
KR101194261B1 (en) | Cleansing composition for hair loss and promotion of hair growth without hypertension | |
CN112353713A (en) | Hair care and hair loss prevention composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |